Active Shortage

JAMP-RISPERIDONE

JAMP PHARMA CORPORATION

View this drug's full profile page →

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of JAMP-RISPERIDONE in Canada?

Yes. JAMP-RISPERIDONE 1MG has an active shortage reported to Health Canada (last updated November 4, 2025).

Why is JAMP-RISPERIDONE not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will JAMP-RISPERIDONE be available again?

The estimated resolution date (January 15, 2026) has passed, but the report has not been updated yet. Follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist — only products with a different form or route found

StatusActive Shortage

Same-ingredient products on file6 products · 0 same form & route

Affected strength1MG

Report last updated2025-11-04

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

RIVA-RISPERIDONE

LABORATOIRE RIVA INC.

1MG · DIN 02283581

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

PRO-RISPERIDONE

PRO DOC LIMITEE

0.25MG · DIN 02312700

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

APO-RISPERIDONE

APOTEX INC

2.0MG · DIN 02282143

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

MINT-RISPERIDON

MINT PHARMACEUTICALS INC

3.0MG · DIN 02359839

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

TEVA-RISPERIDONE

TEVA CANADA LIMITED

4MG · DIN 02264234

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

RISPERIDONE

SANIS HEALTH INC

0.25MG · DIN 02356880

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Estimated Resolution

2026-01-15

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02454319

Strength

1MG

Dosage Form

SOLUTION

Route

ORAL

Active Ingredient

RISPERIDONE

Tier

Unrated

Last Updated

2025-11-04

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from JAMP PHARMA CORPORATION

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACTIVATED CHARCOAL

225MG · DIN 02420694

AMIKACIN SULFATE INJECTION

250MG · DIN 02529459

AMIODARONE HYDROCHLORIDE FOR INJECTION

50MG · DIN 02423227

5MG · DIN 02429217

10MG · DIN 02429225

2.5MG · DIN 02492199

DIN 02532174

DIN 02532182

AZITHROMYCIN FOR INJECTION

500MG · DIN 02523825

BACLOFEN INJECTION USP

2MG · DIN 02553341

BENDAMUSTINE HYDROCHLORIDE FOR INJECTION

100MG · DIN 02509172

BENDAMUSTINE HYDROCHLORIDE FOR INJECTION

25MG · DIN 02509164